Skip to main content
Clinical Trials/IRCT20190312043030N2
IRCT20190312043030N2
Recruiting
Phase 3

The effect of combination of selenium, vitamin C and methylprednisolone in acute respiratory distress syndrome mortality and morbidity from COVID-19

Tabriz University of Medical Sciences0 sites40 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
COVID-19.
Sponsor
Tabriz University of Medical Sciences
Enrollment
40
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Positive PCR test for Covid 19
  • Diffuse asymmetric pulmonary involvement on CT scan complies with Covid\-19
  • Absence of evidence of liquid overload.
  • PaO2/FiO2 ratio \=300 and \>200 is mild ARDS; PaO2/FiO2 ratio100\-200 is moderate ARDS; PaO2/FiO2 ratio \<100 is severe ARDS
  • new/worsening respiratory symptoms within 1 week

Exclusion Criteria

  • Corticosteroid history over the past 3 months
  • Sensitivity to vitamin C.
  • Increased sensitivity to selenium.
  • Primary creatinine above 1\.5\.
  • Ethylene glycol poisoning.

Outcomes

Primary Outcomes

Not specified

Similar Trials